Tumor-induced osteomalacia resulting from primary cutaneous phosphaturic mesenchymal tumor: A case and review of the medical literature

Journal of Cutaneous Pathology

Volumn 40, Issue 9, 2013, Pages 780-784

  Gardner, Kevin H ^a   Shon, Wonwoo ^a   Folpe, Andrew L ^a   Wieland, Carilyn N ^a   Tebben, Peter J ^a   Baum, Christian L ^a  

^a MAYO CLINIC   (United States)

Author keywords

hypophosphatemia; Mohs micrographic surgery; oncogenic osteomalacia; phosphaturic mesenchymal tumor; tumor induced osteomalacia

Indexed keywords

ADULT; CASE REPORT; HUMAN; HYPOPHOSPHATEMIA; MALE; METABOLISM; MOHS MICROGRAPHIC SURGERY; ONCOGENIC OSTEOMALACIA; OSTEOMALACIA; PATHOLOGY; PHOSPHATURIC MESENCHYMAL TUMOR; REVIEW; SKIN TUMOR; TUMOR-INDUCED OSTEOMALACIA; COMPLICATION; SKIN NEOPLASMS;

HYPOPHOSPHATEMIA; MOHS MICROGRAPHIC SURGERY; ONCOGENIC OSTEOMALACIA; PHOSPHATURIC MESENCHYMAL TUMOR; TUMOR-INDUCED OSTEOMALACIA;

ADULT; HUMANS; MALE; OSTEOMALACIA; SKIN NEOPLASMS;

EID: 84882993959     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12209     Document Type: Review

References (15)

1. Bahrami A, Weiss SW, Montgomery E, et al. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia. Am J Surg Pathol 2009; 33: 1348.
2. Ozawa JC, de Paiva AF, de Prospero JD, Monte O, Scalissi NM, Maeda SS,. Mesenchymal tumor in the calcaneus with oncogenic osteomalacia: a case report. J Clin Oncol 2011; 29: e6.
3. Markou A, Tsiama V, Tournis S, et al. Coexistence of tumor-induced osteomalacia and primary hyperparathyroidism. Endocr Pract 2011; 17: e144.
4. Ogura E, Kageyama K, Fukumoto S, et al. Development of tumor-induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor-23. Intern Med 2008; 47: 637.
5. Oka M, Kamo T, Sasaki E, et al. A case of phosphaturic mesenchymal tumour (mixed connective tissue variant) that developed in the subcutaneous tissue of a patient with oncogenic osteomalacia and produced fibroblast growth factor 23. Br J Dermatol 2007; 157: 198.
6. Dewitt CA, Collins MT, Cowen EW,. Diffuse pain, hypophosphatemia, and a subcutaneous nodule. J Am Acad Dermatol 2007; 57: 509.
7. Poizat F, Wojtusciszin A, Raynaud P, Maitre H, Renard ER, Baldet P,. Foot tumor and diffuse pain: a case of oncogenic osteomalacia [French]. Ann Pathol 2005; 25: 134.
8. Folpe AL, Fanburg-Smith JC, Billings SD, et al. Most osteomalacia- associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 2004; 28: 1.
9. Chong WH, Molinolo AA, Chen CC, Collins MT,. Tumor-induced osteomalacia. Endocr Relat Cancer 2011; 18: R53.
10. Jonsson KB, Zahradnik R, Larsson T, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 2003; 348: 1656.
11. Hodgson SF, Clarke BL, Tebben PJ, Mullan BP, Cooney WP 3rd, Shives TC,. Oncogenic osteomalacia: localization of underlying peripheral mesenchymal tumors with use of Tc 99m sestamibi scintigraphy. Endocr Pract 2006; 12: 35.
12. Takeuchi Y, Suzuki H, Ogura S, et al. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 2004; 89: 3979.
13. Uramoto N, Furukawa M, Yoshizaki T,. Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue. Auris Nasus Larynx 2009; 36: 104.
14. Clunie GP, Fox PE, Stamp TC,. Four cases of acquired hypophosphataemic ('oncogenic') osteomalacia: problems of diagnosis, treatment and long-term management. Rheumatology (Oxford). 2000; 39: 1415.
15. Ogose A, Hotta T, Emura I, et al. Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia. Skeletal Radiol 2001; 30: 99.